BioSpace News Archive

Phase 1 trial underway at the University of Alabama at Birmingham in recurrent glioblastoma multiforme

Data in severe aplastic anemia support potential of NiCord to treat non-malignant bone marrow failure disorders

Dicerna Pharmaceuticals, Inc., a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced the addition of three industry veterans to the Company’s management team

Louisiana health system recognized for achieving 76+ percent reduction in complications for patients undergoing certain surgeries, and more than $815,000 in cost savings

Concert Pharmaceuticals, Inc. announced that it will report its financial results for the year ended December 31, 2018, on Thursday, February 28, 2019, before the U.S. financial markets open.

Landos Biopharma, Inc. announced the publication of findings that further elucidate the regulatory arm of the novel mechanism of action for BT-11, its investigational new drug for Crohn’s disease and ulcerative colitis, in the Journal of Immunology.

Rigel Pharmaceuticals, Inc. announced that it will report its fourth quarter and year end 2018 financial results after market close on Thursday, February 28, 2019.

Ardelyx, Inc. announced that Mike Raab, president and chief executive officer of Ardelyx, will participate in a fireside chat at the Leerink Partners Global Healthcare Conference at 2:30 p.m. ET on Thursday, Feb. 28, 2019 at the Lotte New York Palace Hotel in New York City.

The vast majority of people with asthma may be using their inhalers incorrectly, potentially making their medicine less effective and increasing their risk of asthma attacks, according to new research published in The Journal of Allergy and Clinical Immunology: In practice by digital therapeutics company Propeller Health, in partnership with the University of Colorado School of Medicine and Children’s Hospital Colorado.

Local business adds the Clorox® Total 360® System to its cleaning arsenal to enhance disinfection protocols